News Posts List
Cool trend in IR practice looks for warm reception
08/01/2008
The hottest trend in interventional radiology is also its coldest. Improved technology and growing clinical experience have moved cryoablation into mainstream IR practice. Cryoprobes used to be too large to allow perutaneous intervention. But Endocare (Irvine, CA) recently introduced a 1.7-mm diameter device about one-quarter the size of the previous generation. The industrial leap has made percutaneous image-guided cryoablation possible, said Dr. J. Louis Hinshaw, an interventionalist and assistant professor of abdominal imaging at the University of Wisconsin-Madison. Source: CMP Healthcare Media Group LLC, Diagnostic Imaging Magazine
Uplifting Athletes at Ohio State Raises Awareness for Kidney Cancer
07/31/2008
Inaugural event a great experience for players and fans
Ohio State Football Uplifting Athletes to Host Video Game Tournament
07/30/2008
Ohio State football student-athletes have started a student organization called Uplifting Athletes, joining other college football programs in an effort to make rare diseases better known. Their first event will be a college football video game tournament on Wednesday, July 30, at Eddie George's Grille 27 from 4 - 8 p.m. The event will raise funds for the Kidney Cancer Association and increase awareness for this rare disease.
Medicare changes threaten clinics' survival
07/30/2008
Survivor raises funds for Kidney Cancer Association
07/27/2008
Two year survivor Ashraf Khalil is selling homemade Hummus and Baba Ghanoog to benefit the Kidney Cancer Association. Please read below for more information.
New treatment option for kidney cancer
07/24/2008
NEW YORK July 24, 2008 Patients treated for kidney cancer that has spread to other organs live longer without the cancer advancing when treated with a new drug, researchers say. The new drug is called everolimus and the study led by Dr. Robert Motzer, of Memorial Sloan-Kettering Cancer Center, showed that the drug prolongs progression-free survival relative to placebo in patients who have experienced treatment failure on other regimens. The results of the study appear yesterday in an early online edition of The Lancet. Source: Cancerfacts.com
Conductor James Levine had malignant kidney growth
07/23/2008
BOSTON A growth on a kidney removed from conductor James Levine was malignant, but the cancer was caught early and no further treatment is needed, the Boston Symphony Orchestra said Tuesday. Source: Foxnews.com
News Feed